Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 10 - K ANNUAL REPORT UNDER SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended : December 31 , 2020 TRANSITION REPORT UNDER SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Nevada ( State or other jurisdiction of incorporation or organization ) to Commission file number : 001-38793 INMUNE BIO INC . ( Exact name of registrant as specified in its charter ) INMUNE BIO INC . David Moss 1200 Prospect Street , Suite 525 La Jolla , CA 92037 Phone : ( 858 ) 964 3720 ( Address of principal executive offices ) ( Zip Code ) ■ XX 47-5205835 ( I.R.S. Employer Identification No. ) ( 858 ) 964 3720 ( Registrant's telephone number , including area code ) Securities registered pursuant to Section 12 ( b ) of the Act : None Securities registered pursuant to Section 12 ( g ) of the Act : Title of each class Common Stock ( $ .001 par value ) Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes No Name of Market Where Traded The Nasdaq Stock Market LLC Indicate by checkmark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( § 232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit and post such files ) . Yes > No □ Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , smaller reporting company , or an emerging growth company . See the definitions of “ large accelerated filer , ” “ accelerated filer , ” “ smaller reporting company , " and " emerging growth company ” in Rule 12b - 2 of the Exchange Act . Accelerated filer Smaller reporting company Large accelerated filer Non - accelerated filer Emerging Growth Company If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Exchange Act ) . Yes No The aggregate market value of the registrant's common stock held by non - affiliates of the registrant was approximately $ 21.2 million as of the last business day of the registrant's most recently completed second fiscal quarter ( June 30 , 2020 ) , based upon the closing sale price for the registrant's common stock on that day as reported by the NASDAQ Capital Market . Shares of common stock held by each officer and director of the registrant on June 30 , 2020 have been excluded in that such persons may be deemed to be affiliates . As of March 4 , 2021 , there are 14,932,638 shares of common stock , $ 0.001 par value per share outstanding . | □ X